Amas, Ritchel T.
HRN: 19-07-51 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/07/2025
CEFUROXIME 1.5GM (VIAL)
11/07/2025
11/14/2025
IVT
1.5gms
On Call To OR Then Q 8
Pelvic Laparotomy
Checking Initial Appropriateness
11/07/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/07/2025
11/14/2025
IVT
500 Mg
Q8
Pelvic Laparotomy
Checking Initial Appropriateness